Loading clinical trials...

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS] | Clinical Trials | Clareo Health

COMPLETEDNA

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

First Study Evaluating Efficiency and Safety of a Compressive Device to Prevent Keloid Scars Recurrence After Surgery

NCT03312166•Centre Hospitalier Universitaire de Besancon

Summary

SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to the prevention of keloïd scars recurrence after surgery. The tested device is made with clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and follow during one year. The primary outcome of this study is the number of keloid recurrence after treatment.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient over 18 yo;
•Patient with aer lobe keloid;
•Patient with an indication of reconstructive surgery;
•Signature of informed consent from the patient;
•Indication that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study;
•Patient with French social insurance.

Exclusion Criteria

•Patient with cutaneous dermatosis or other skin pathology able to interfere with evaluated parameter (recurrence and healing quality);
•Patient with know nickel allergy;
•Patient with know silicon allergy;
•Pregnant women;
•Legal incapacity or limited legal capacity;
•Patient unlikely to cooperate in the study and / or low cooperation anticipated by the investigator;
•Patient without health insurance;
•The patient is in the period of exclusion of another study.

Locations (1)

CHU de Besançon

Besançon, France

Key Dates

Start Date

October 3, 2017

Primary Completion Date

December 14, 2023

Completion Date

December 14, 2023

Last Updated

September 19, 2024

Enrollment

ACTUAL participants

Conditions

Keloid

Interventions

Compression device

DEVICE

Topical Cryotherapy and Keloid/Hypertrophic Scars

NCT07336368

Keloid ScarsHypertrophic Scars

View study

RECRUITINGPHASE2

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

NCT06373458

Keloid

View study

RECRUITING

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

Inclusion Criteria

Exclusion Criteria

Topical Cryotherapy and Keloid/Hypertrophic Scars

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

A Prospective Observational Clinical Study on Exploring the Value of Surgical Excision Combined With 32P Application in the Treatment of Keloids and the Factors Affecting the Prognosis of Combined Therapy

The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial.

A Pilot Study to Explore the Role of Gut Flora in Acne